
Swiss multinational Novartis has withdrawn a European Medicines Agency (EMA) marketing application for canakinumab for the prevention of serious events …

Sanofi’s fexinidazole, the first all-oral therapy for the treatment of human African trypanosomiasis (HAT), or sleeping sickness, has secured a …

In July of this year the European Medicines Agency (EMA) identified significant gaps in the pharmaceutical industry’s preparedness for Brexit. …

Sarepta Therapeutics has been rocked by a hurdle in its pursuit of regulatory approval in Europe, as the company revealed …

What does Brexit mean for drug safety in Europe and the United Kingdom? Louis Goss looks into Britain’s exit from …

Brexit took the top two spots this week after it was revealed that the EMA has awarded Britain’s MHRA just …

The EMA has awarded Britain’s regulatory body the MHRA just two contracts this year, as the European agency suggested that …

While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …

The European Medicines Agency is set to enact temporary cuts in activities as it prepares for significant disruption in the …

Pfizer is patting itself on the back after securing two new approvals in Europe within 24 hours: Xeljanz (tofacitinib citrate) …

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of two separate …

A British landlord is taking the European Medicines Agency (EMA) to court over a £500 million bill for unpaid rent. …

British MPs have voted for the UK’s continued participation in the regulatory network operated by the European Medicines Agency (EMA) …

In the week leading up to Donald Trump’s visit to the United Kingdom, the news has been dominated by the …

An EMA survey has identified gaps in the pharmaceutical industry’s preparedness for Brexit, finding that only 58% of market authorisation …